FeesSafety
Pluang+

Onconetix announces 1-for-10 reverse stock split effective Nov 6, 2026, to reduce outstanding shares.

Company Fundamentals
27 Oct 2026, 00:03 WIB
GlobeNewsWire
View Source
Neutral
Onconetix announces 1-for-10 reverse stock split effective Nov 6, 2026, to reduce outstanding shares.

Onconetix, Inc. announced a one-for-ten reverse stock split of its common stock, effective November 6, 2026. This move will reduce the number of outstanding shares from about 5.9 million to approximately 589,000, while keeping the total authorized shares and par value unchanged. The reverse split will not affect shareholders' ownership percentages except for fractional shares, which will be paid in cash. The company's stock will continue trading on Nasdaq under the symbol "ONCO." This action aims to consolidate shares and potentially improve stock liquidity and market perception.

Onconetix's reverse stock split announcement provides context for health sector trading activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 27, 2026 04:12 WIB: Out of 150 priced health-sector US stocks, 81 rose and 69 fell today. Notable movers include TNGX at USD 22.09 with a 1-day change of -5.36% and Pluang order activity showing 14% Sell / 86% Buy, BNGO at USD 1.12 down 5.08% with 100% Sell orders, and IBRX at USD 7.81 down 4.99%, with typical hold times ranging from 2 to 51 days on Pluang.

More News

Presidio named Global Innovation Partner of the Year at Cisco Partner Summit 2026

Presidio named Global Innovation Partner of the Year at Cisco Partner Summit 2026

At the Cisco Partner Summit 2026, Presidio was honored as the Global Innovation Partner of the Year, recognizing its outstanding innovation and success in delivering impactful customer solutions. This award highlights Presidio's commitment to partner...

Market News
Bullish
58 minutes ago
Presidio named Global Services and Software Excellence Partner of the Year at Cisco Partner Summit 2026

Presidio named Global Services and Software Excellence Partner of the Year at Cisco Partner Summit 2026

Presidio was awarded the Global Services and Software Excellence Partner of the Year at the Cisco Partner Summit 2026. This award recognizes Presidio's outstanding innovation and success in delivering solutions that help customers achieve meaningful ...

Market News
Bullish
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
2 hours ago
Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
2 hours ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App